MSH Radiopeptides for Targeting Melanoma Metastases
- 1 January 2010
- book chapter
- Published by Springer Nature
- Vol. 681, 133-142
Abstract
Radiolabeled peptides have become important tools for preclinical cancer research and in nuclear oncology they serve as diagnostic and more recently also as therapeutic agents. Whereas the development of receptor-mediated targeting for therapy has been confined to some radiolabeled antibodies and somatostatin/SRIF analogs, recent research into radiolabeled α-Melanocyte-stimulating hormone (α-MSH) and its receptor MC1R (over-)expressed by melanoma tumor cells has demonstrated that small metastatic melanoma lesions in experimental animals are specifically targeted by MSH radiopeptides. Thus MSH radiopharmaceuticals will eventually open a new avenue for the treatment of melanoma metastases in man, provided that the targeting efficiency can be further enhanced and nonspecific incorporation into nontarget organs, e.g., the kidneys, minimized. Some novel MSH lead compounds containing a glyco moiety, added negatively charged groups or a cyclic structure show very promising in vivo targeting characteristics.Keywords
This publication has 35 references indexed in Scilit:
- Effect of DOTA Position on Melanoma Targeting and Pharmacokinetic Properties of 111In-Labeled Lactam Bridge-Cyclized α-Melanocyte Stimulating Hormone PeptideBioconjugate Chemistry, 2009
- Melanoma imaging using 111In-, 86Y- and 68Ga-labeled CHX-A″-Re(Arg11)CCMSHNuclear Medicine and Biology, 2009
- Metastatic melanoma imaging with an 111In-labeled lactam bridge-cyclized α-melanocyte-stimulating hormone peptideNuclear Medicine and Biology, 2009
- Peptide-targeted radionuclide therapy for melanomaCritical Reviews in Oncology/Hematology, 2008
- 111In-Labeled Lactam Bridge-Cyclized α-Melanocyte Stimulating Hormone Peptide Analogues for Melanoma ImagingBioconjugate Chemistry, 2008
- A 99mTc(CO)3-labeled pyrazolyl–α-melanocyte-stimulating hormone analog conjugate for melanoma targetingNuclear Medicine and Biology, 2007
- 64Cu-Labeled Alpha-Melanocyte-Stimulating Hormone Analog for MicroPET Imaging of Melanocortin 1 Receptor ExpressionBioconjugate Chemistry, 2007
- Reducing renal uptake of 90Y- and 177Lu-labeled alpha-melanocyte stimulating hormone peptide analoguesNuclear Medicine and Biology, 2006
- Tumor-targeting properties of 90Y- and 177Lu-labeled α-melanocyte stimulating hormone peptide analogues in a murine melanoma modelNuclear Medicine and Biology, 2005
- Monoclonal antibodies as therapeutic agents for cancerThe Lancet Oncology, 2004